Skip to main content
. 2018 Aug 8;12:255. doi: 10.3389/fncel.2018.00255

Figure 5.

Figure 5

Impact of FGFR inhibitor (SU5402) on the microglia activation in hippocampus. (A1–A3) Representative photographs of Iba1 expression in hippocampus. Compared with the DMSO group, there were increased expression of microglia identification marker Iba1 and more Iba1 positive cells in CA1 and DG with the swollen soma and retracted processes in 5 μg dose of SU5402 group. (B) The percentage of Iba1 positive area was increased by 5 μg dose of SU5402. (C) The density of Iba1 positive cells was increased by 5 μg dose of SU5402. (D) The area of microglia soma was increased by 5 μg dose of SU5402. (E) The length of microglial processes was decreased by 5 μg dose of SU5402. One-way ANOVA with Dunnett’s multiple comparisons test, n = 4 per group. Data are presented as the means ± SEM. **p < 0.01, ***p < 0.001. DMSO, dimethyl sulfoxide; DG, dentate gyrus.